Discontinued — last reported Q4 '23
Incyte Japan — PP&E (Net) increased by 220.0% to $4.80M in Q4 2023 compared to the prior quarter.
An increase suggests ongoing capital investment or expansion of regional infrastructure, while a decrease may indicate asset depreciation, divestment, or a shift toward asset-light operational models.
This metric represents the net book value of tangible assets, such as laboratory equipment, office facilities, and infra...
Peers in the pharmaceutical industry typically report regional property and equipment to demonstrate the scale of their local commercial and research footprint, with values varying based on whether the company owns or leases its facilities.
incy_segment_japan_property_and_equipment_net| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $2.90M | $1.50M | $4.80M |
| QoQ Change | — | -48.3% | +220.0% |
| YoY Change | — | -48.3% | +220.0% |